These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7407784)

  • 1. Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part III. Assessing measurement techniques in psychosocial oncology.
    Morrow GR
    Cancer Treat Rep; 1980; 64(2-3):451-6. PubMed ID: 7407784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part I. Introduction.
    Schmale AH
    Cancer Treat Rep; 1980; 64(2-3):441-3. PubMed ID: 7407782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part II. Assessing reliability with equal-appearing interval scales.
    Feldstein ML
    Cancer Treat Rep; 1980; 64(2-3):445-50. PubMed ID: 7407783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of toxicity: statistical considerations.
    Herson J
    Cancer Treat Rep; 1980; 64(2-3):463-8. PubMed ID: 7407785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitrait-multimethod models in aging research.
    Widaman KF
    Exp Aging Res; 1992; 18(3-4):185-201. PubMed ID: 1459163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the convergent and discriminant validity of states and traits: development and applications of multimethod latent state-trait models.
    Courvoisier DS; Nussbeck FW; Eid M; Geiser C; Cole DA
    Psychol Assess; 2008 Sep; 20(3):270-80. PubMed ID: 18778163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of Canadian oncology practitioners toward psychosocial interventions in clinical and research settings in women with breast cancer.
    Del Giudice ME; Leszcz M; Pritchard KI; Vincent L; Goodwin P
    Psychooncology; 1997 Sep; 6(3):178-89. PubMed ID: 9313283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On construct validity: issues of method and measurement.
    Smith GT
    Psychol Assess; 2005 Dec; 17(4):396-408. PubMed ID: 16393005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construct validity of dimensions of adaptive behavior: a multitrait-multimethod evaluation.
    Widaman KF; Stacy AW; Borthwick-Duffy SA
    Am J Ment Retard; 1993 Sep; 98(2):219-34. PubMed ID: 8398082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 25-year review of sequential methodology in clinical studies.
    Todd S
    Stat Med; 2007 Jan; 26(2):237-52. PubMed ID: 17139691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The construct validity of acceptance: a multitrait-multimethod investigation.
    Kollman DM; Brown TA; Barlow DH
    Behav Ther; 2009 Sep; 40(3):205-18. PubMed ID: 19647522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meaning and its measurement in psychosocial oncology.
    White CA
    Psychooncology; 2004 Jul; 13(7):468-81. PubMed ID: 15227716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific rigour in psycho-oncology trials: why and how to avoid common statistical errors.
    Bell ML; Olivier J; King MT
    Psychooncology; 2013 Mar; 22(3):499-505. PubMed ID: 22315186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent personality: a five-factor model construct validation.
    Baker SR; Victor JB; Chambers AL; Halverson CF
    Assessment; 2004 Dec; 11(4):303-15. PubMed ID: 15486167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards understanding assessments of the big five: multitrait-multimethod analyses of convergent and discriminant validity across measurement occasion and type of observer.
    Biesanz JC; West SG
    J Pers; 2004 Aug; 72(4):845-76. PubMed ID: 15210019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trials.
    McKenna SP; Doward LC; Meads DM; Tennant A; Lawton G; Grueger J
    Health Qual Life Outcomes; 2007 Jul; 5():45. PubMed ID: 17662129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges to behavioral research in oncology.
    Mock V; Hill MN; Dienemann JA; Grimm PM; Shivnan JC
    Cancer Pract; 1996; 4(5):267-73. PubMed ID: 9004573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical issues in psychosocial measures.
    Wolfe F
    J Rheumatol; 1997 May; 24(5):990-3. PubMed ID: 9150097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases.
    Lonn E
    Pharmacoepidemiol Drug Saf; 2001; 10(6):497-508. PubMed ID: 11828831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.